Post-Warning Letter Meetings Under GDUFA
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 20, 2025
June 20, 2025
4176915b-4275-4264-96ff-88a64a4f46e7
Related Documents
Requests for Reconsideration at the Division Level Under GDUFA
Guidance DocumentOctober 16, 2024Center for Drug Evaluation and Research
Product-Specific Guidance Meetings Between FDA and ANDA Applicants Under GDUFA: Guidance for Industry
Guidance DocumentAugust 20, 2024Center for Drug Evaluation and Research
Facility Readiness: Goal Date Decisions Under GDUFA
Guidance DocumentJune 18, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox